Skip To Main Content
Rocio Sedano on Muck Rack

Rocio Sedano

As seen in: Color Research & Application, Gastroenterology
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile
Back to Rocio Sedano’s profile

Articles by Rocio Sedano

Editorial: standardising inclusion and outcome criteria for pouchitis-a fragile consensus perhaps but a first step in the right direction. Authors' reply - Sedano - 2021 - Alimentary Pharmacology & Therapeutics - Wiley Online Library

|
By Rocio Sedano, Christopher Ma, Vipul Jairath
| Color Research & Application Verified
INVITED EDITORIAL Vipul Jairath Corresponding Author vipul.jairath@robartsinc.com orcid.org/0000-0002-1092-0033 Division of Gastroenterology, Department of Medicine, Western University, London, ON, Canada Alimentiv Inc (formerly Robarts Clinical Trials Inc), London, ON, Canada Departments of Epidemiology and Biostatistics, Western University, London, ON, Canada Search for more papers by this author PDF ShareShare Abstract LINKED CONTENT This article is linked to Sedano et al and Laube &...
Open in Who Shared Issue with article?

An expert consensus to standardise clinical, endoscopic and histologic items and inclusion and outcome criteria for evaluation of pouchitis disease activity in clinical trials

|
By Rocio Sedano, ON Canada, Christopher Ma, Rish K Pai
| Color Research & Application Verified
ORIGINAL ARTICLE The complete affiliations for all authors are listed in Appendix  1. The Handling Editor for this article was Professor Jonathan Rhodes, and it was accepted for publication after full peer‐review. Summary Background Pouchitis is a condition with large unmet medical needs and no approved therapies. Lack of validated instruments to measure disease activity and treatment response is a major barrier to drug development.
Open in Who Shared Issue with article?

An international consensus to standardize integration of histopathology in ulcerative colitis clinical trials

|
By Christopher Ma, Ahmed Almradi, Niels Vande Casteele, Rocio Sedano
| Gastroenterology Verified
This paper is only available as a PDF. To read, Please Download here. ABSTRACT Background & Aims Histopathology is an emerging treatment target in ulcerative colitis (UC) clinical trials. We aim to provide guidance on standardizing biopsy collection protocols, identifying optimal evaluative indices, and defining thresholds for histologic response and remission after treatment.
Open in Who Shared Issue with article?
Show More